Restylane® Fynesse (1x1ml) - Aesthetic Pharma Sp. z o.o.
This shop uses cookies and other technologies so that we can improve your experience on our sites. close

Restylane® Fynesse (1x1ml)

New product

323,70 zł tax excl.

404,63 zł tax excl.


Buy 3 packs 25% discount.

If you buy more, please contact us.

More details


Non-animal cross-linked hyaluronic acid. The main component of Restylane® (before: Emervel®) is hyaluronic acid. This is a naturally occurring substance found in all living organisms. The hyaluronic acid is mixed with a cross-linker called Butanediol Diglycidyl Ether (BDDE) to form a gel, which is then purified through dialysis to remove trace amounts of BDDE left over from the process.

The hyaluronic acid in Restylane® is produced by a biotechnological process from bacterial fermentation without using any animal products.

Restylane® benefits from what the manufacturers call its Optimal Balance Technology™.

Restylane® has 4 levels of cross-linking, resulting in 4 levels of gel firmness across the range. Particle size or calibration is achieved during the manufacturing process after cross-linking, by sieving the gels through different sizes of mesh.

Hyaluronic acid is completely broken down within the skin over a period of months, eventually leaving no trace of the filler.

Restylane® Fynesse (Emervel® Touch) is a soft and subtle formulation for the treatment of superficial wrinkles, such as peri-oral lines (around the mouth) and peri-orbital lines (around the eyes, crow’s feet). It is injected into the superficial dermis.

The Optimal Balance Technology™, employed in the manufacture of Emervel, provides a product which lasts for 6 - 9 months. In clinical trials, some effects have also been seen at 12 months.

  • smooth wrinkles around the eyes (known as crow's feet),
  • peri-oral lines (around the mouth),
  • fine lines on the forehead and upper face.


Hyaluronic Acid: 20 mg/ml

Lidocaine: -


1 x 1 ml prefilled syringe

needles: 2 x 30G 1/2 "ultra thin wall"

  • hypersensitivity to one of the components,
  • skin infection near the site of injection,
  • patients susceptible to keloid formation,
  • pregnant or lactating women,
  • allergy or anaphylaxis,
  • bleeding disorders,
  • autoimmune disorders,
  • antibiotic therapy.

Read the package leaflet before use.


SAFETY only original products
CALENDAR terms congresses
NEWS in aesthetic medicine